Post-ET MF
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| MPN-RC 118 AVID200 in Myelofibrosis (NCT03895112) | John Mascarenhas | 2019-02-15 |
| Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF (NCT01644110) | University of Ulm | 2013-08-01 |
Track Post-ET MF automatically
Every clearance here is in the API, with alerts when new ones post.